title: Imaging hypertrophic heart diseases with cardiovascular MR.
abstract: The assessment of ventricular hypertrophy is an increasingly common indication for cardiac MR (CMR) in every day clinical practice. CMR is useful to confirm the presence of hypertrophy and to help to define the underlying cause through a combination of a detailed assessment of ventricular function and tissue characterising sequences. As well as being a useful diagnostic tool, some CMR imaging features are of prognostic significance. In this article, we review the typical appearances of common forms of ventricular hypertrophy, focussing principally on left ventricular hypertrophy, and demonstrate the techniques that can be used to differentiate one form of hypertrophy from another.
authors.affiliation: Department of Cardiothoracic Radiology, Southampton University Hospitals NHS Trust, Southampton, UK.
authors.forename: Robin D
authors.initials: RD
authors.lastname: Proctor
authors.forename: James S
authors.initials: JS
authors.lastname: Shambrook
authors.forename: Paula
authors.initials: P
authors.lastname: McParland
authors.forename: Charles R
authors.initials: CR
authors.lastname: Peebles
authors.forename: Ivan W
authors.initials: IW
authors.lastname: Brown
authors.forename: Stephen P
authors.initials: SP
authors.lastname: Harden
mesh_terms: D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis* / Q000503:physiopathology; D005260:Female; D005682:Gadolinium; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000175:diagnosis* / Q000503:physiopathology; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D011379:Prognosis; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index
chemical_list: D005682:Gadolinium